E-mail not displaying correctly? View it in your browser.
Our Products
& Services
Click to find
more about our
 



 
In this newsletter

Cyprotex offers long-term toxicity screening using InSphero's 3D liver models
InSphero offers together with Cyprotex a new screening service to provide its customers with advanced cellular models of drug-induced toxicity in the liver. Find more product details here or get an offer now!


Join our US User Group Meeting on 3D cell culture in BOS on Oct 29 & SFR on Nov 1
Our next half- to full-day meetings in Boston and San Francisco will bring together experts in the use of 3D cell culture in efficacy and toxicology testing. View the preliminary program or register by e-mail now!
*** Free participation for all InSphero customers! ***


Malvika Bhatt joins InSphero's USA sales team
We are happy to announce that Malvika Bhatt has joined our USA sales team on the East Coast. Welcome Malvika! Read more here.
 

3D cell culture literature picks – Sep 2012
Our applications team has reviewed a small selection of current 3D-cell-culture journal papers  to keep you updated about recent developments in 3D.

Meet InSphero at fairs & events
Meet the InSphero team at upcoming fairs, conferences and workshops to learn how 3D microtissues accelerate the process of drug discovery and development. Arrange a meeting, a webinar or register for User Group Meeting.
About InSphero
 
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company, headquartered in Zurich, Switzerland, currently counts 7 of the top ten global pharmaceutical and cosmetics companies as customers, and is helping them implement the company’s patent-pending microtissue technology in their development work-flow. InSphero 3D Insight™ Microtissues enable more biologically relevant in vitro applications in efficacy (e.g. in oncology) and toxicology, including long-term and inflammation-mediated toxicity. A broad portfolio of tumor and liver microtissues is available from a number of cell sources, with additional toxicology models in the pipeline. The spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich has been recognised for its scientific and commercial achievements with a number of national and international awards and is also certified to the ISO 9001:2008 standard for its Quality Management System.

Our mailing address is:
InSphero Inc.
74 Orion St
Techplace
Brunswick, ME 04011-5031


Copyright (C) 2012 InSphero Inc. All rights reserved.